Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogamulizumab Q4W in R/R CTCL
NCT04745234Phase 2Active, not recruiting
- Sponsor
- Kyowa Kirin
- Start
- Aug 2021
- Primary completion
- May 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of mogamulizumab in cutaneous T-cell lymphoma (CTCL), sponsored by Kyowa Kirin. Started Aug 2021; status: active, not recruiting.
02
Drugs
mogamulizumab
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT04745234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04745234.